Stratum | No. IPTI : placebo | mean MOI (median, range) | P | Proportion of polyclonal infections (%) | P | ||
---|---|---|---|---|---|---|---|
Previous IPTi | Previous Placebo | Previous IPTi | Previous Placebo | ||||
All | 191 : 198 | 2.25 (2, 1-5) | 2.33 (2, 1-6) | 0.55 | 69.6 | 69.7 | 0.99 |
All microscopically positive | 135 : 142 | 2.42 (2, 1-5) | 2.38 (2, 1-6) | 0.78 | 74.8 | 72.5 | 0.67 |
Afigya Sekyere | 85 : 88 | 2.29 (2, 1-5) | 2.31 (2, 1-6) | 0.92 | 69.4 | 71.6 | 0.75 |
Tamale, all | 106 : 110 | 2.22 (2, 1-5) | 2.35 (2, 1-5) | 0.49 | 69.8 | 68.2 | 0.80 |
Tamale, microscopically positive | 50 : 54 | 2.64 (2.5, 1-5) | 2.50 (2, 1-5) | 0.59 | 84.0 | 74.1 | 0.22 |
Tamale, submicroscopic | 56 : 56 | 1.84 (2, 1-5) | 2.20 (2, 1-5) | 0.17 | 57.1 | 62.5 | 0.56 |